Unforgettable tetanus

European Journal of Anaesthesiology

Volumn 14, Issue 2, 1997, Pages 122-133

  Attygalle, D ^a   Karalliedde, L ^b  

^a National Hospital Sri Lanka   (Sri Lanka)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROMAZINE; CLONIDINE; DANTROLENE; MAGNESIUM; MEPHENESIN; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; TETANUS TOXIN;

AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; DEVELOPING COUNTRY; DISEASE SEVERITY; HUMAN; IMMUNIZATION; MUSCLE SPASM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; REVIEW; SEDATION; SYMPTOMATOLOGY; TETANUS;

EID: 0030875931     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199703000-00003     Document Type: Review

References (83)

1. Brabin L, Kemp J, Maxwell SM, Ikimalo J, Obunge OK, Briggs ND. Protecting adolescent girls against tetanus (editorial). Br Med J 311: 73-74.
2. Sanford JP. Tetanus - Forgotten but not gone. N Eng J Med 1995; 332: 812-813.
3. Karalliedde L, Cumberland N, Alexander C. Unfinished business: adult immunization against tetanus. World Health Forum 1995; 16: 374-376.
4. Whitman C, Belghari L, Gane F, Torel C, Mattei V, Zoffmann H. Progress towards the global elimination of neonatal tetanus. World Health Stat Q - Rapport Trimestriel de Statisques Sanitaires Mondiales 1992; 45: 248-256.
5. Sutter RW, Cochi SL, Brink EW, Sirotkin BI. Assessment of vital statistics and surveillance data for monitoring tetanus mortality. United States 1979-1984. Am J Epidemiol 1990; 131: 132-142.
6. Galazka A, Gasse F. The present status of tetanus and tetanus vaccination. Curr Top Microbiol Immunol 1995; 19: 31-53.
7. Summary of notifiable diseases - United States 1992. MMWR Morb Mortal Wkly Rep 1992; 41: 67.
8. Luisto M. Epidemiology of tetanus in Finland from 1969 to 1985. Scand J Infect Dis 1989; 21: 655-663.
9. Galazka A, Kardymowicz B. Tetanus incidence and immunity in Poland. Bur J Epidemiol 1989; 5: 474-480.
10. Simonsen O, Bloch AV, Heron I. Epidemiology of tetanus in Denmark 1920-1982. Scand J Infect Dis 1987; 19: 437-444.
11. Expanded Programme on Immunization (EPI). Reassessment of the neonatal tetanus problem in China. Wkly Epidemiol Rec 1993; 68: 201-204.
12. Bennett JV, Seward J, Sakai S, Wang LD. Identifying areas of high-risk for neonatal tetanus. Lancet 1995; 346: 1628-1629.
13. Melgaard B, Mutie DM, Kimain G. Int J Epidemiol 1988; 17: 174-177.
14. Harding-Goldson HE, Hanna WJ. Tetanus: a recurring intensive care problem. J Trop Med Hygiene 1995; 98: 179-184.
15. Wilkins CA, Richter MB, Hobbs WB, Whitcomb M, Bergh N, Carstens J. Occurrence of Clostridium tetani in soil and horses. S Afr Med J 1988; 73: 718-720.
16. Dastur FD, Awatramani VP, Chitra SK, D'Sa JA. A single dose vaccine to prevent neonatal tetanus. J Assoc Phys India 1993; 41: 97-99.
17. Fauvea V, Mamdani M, Steinglass R, Koblinsky M. Maternal tetanus: magnitude, epidemiology and potential control measures. Int J Gynaecol Obst 1993; 40: 3-12.
18. Afonja AO, Jalyeola BO, Tunwashe OL. Tetanus in Lagos: a review of 228 adult Nigerian patients. J Trop Med Hyg 1973; 76: 171-174.
19. Bleck TP. Tetanus: dealing with continuing clinical challenge. J Crit Illness 1987; 2: 41-52.
20. Dominghetti M, Savary G, Stricker H. Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol. Br Med J 1984; 288: 1483-1484.
21. Tsueda K, Oliver PB, Richter RW. Cardiovascular manifestations of tetanus. Anesthesiology 1974; 40: 588-592.
22. Mellanby J, Green J. How does tetanus toxin act? Neuroscience 1981; 6: 281-300.
23. Bevan S, Wendon LMB. A study of the action of tetanus toxin at rat soleus neuromuscular junctions. J Physiol 1984; 348: 1-17.
24. Bergey GK, MacDonald RL, Habiq WH, Herdegree MC, Nelson PG. Tetanus toxin: convulsant action on mouse spinal cord neurons in culture. J Neurosci 1983; 3: 2310-2323.
25. Bigalke H, Heller I, Bizzini B, Haberman E. Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn-Schmiedebergs Arch Pharmacol 1981; 316: 244-251.
26. Collingridge GL, Collins GGS, Davies J, James TA, Neal MJ, Tongroach P. Effect of tetanus toxide on transmitter release from the substantia nigra and striatum in vitro. J Neurochem 1980; 34: 540-547.
27. Egea G, Rebasseda X, Solsona C, Marsal J, Bizzini B. Tetanus toxin blocks potassium-induced transmitter release and rearrangement of intramembrane particles at pure cholinergic synaptosomes. Toxicon 1990; 28: 311-318.
28. Curtis DR, Felix D, Game CJA, McCulloch RM. Tetanus toxin and the synaptic release of GABA. Brain Res 1973; 51: 358-362.
29. Curtis DR, de Groat WC. Tetanus toxin and spinal inhibition. Brain Res 1968; 10: 208-212.
30. De Sarro GB, Bagetta G, Nistico G. Antagonism by drugs enhancing gabaergic transmission of central effects of tetanus toxin in rats. In: Nistico P, Mastroeni P and Pitzurra M eds. Seventh International Conference on Tetanus. Rome: Gangemi Publ Co Roma, 1985: 129-141.
31. Senanayake N, Karalliedde L. Tetanus. National Education Series. No 8. Sri Lanka, 1985.
32. Burgess JA, Wambaugh GW, Koczarski MJ. Report of case: reviewing cephalic tetanus. J Am Dent Assoc 1992; 123: 67-70.
33. Luisto M. Unusual and iatrogenic sources of tetanus. Ann Chirurg Gynaecol 1993; 82: 25-29.
34. Sow PS, Diop BM, Barry HL, Badiane S, Coll-Seck AM. Tetanus and traditional practices in Dakar: report of 141 cases. Dakar Med 1993; 38: 55-59.
35. Yen LM, Dao LM, Day NP et al. Role of quinine in the high mortality of intramuscular injection tetanus. Lancet 1994; 344: 786-787.
36. Sun KO, Chan YW, Cheung RTF, So PC, Yu YL, Li PCK. Management of tetanus: a review of 18 cases. J Roy Soc Med 1994; 87: 135-137.
37. Bennett J, Azhar N, Rahim F et al. Further observations on ghee as a risk factor for neonatal tetanus, Int J Epidemiol 1995; 24: 643-647.
38. Senanayake N, Karalliedde L. Cephalic tetanus. Jaffna Med J 1980; 25: 23-26.
39. Jagoda A, Riggio S, Burguieres T. Cephalic tetanus: a case report and review of the literature. Am J Emerg Med 1988; 6: 128-130.
40. Dutta TK, Padmanabhan S, Hamide A, Ramesh J. Localised tetanus mimicking incomplete transverse myelitis. Lancet 1994; 343: 983-984.
41. Kerr JH, Corbett JL, Prys-Roberts C, Crampton Smith A, Spalding JMK. Involvement of the sympathetic nervous system in tetanus. Lancet 1968; ii: 236-241.
42. Rose AG. Catecholamine-induced myocardial damage associated with phaechromocytoma and tetanus. S Afr Med J 1974; 48: 1285-1289.
43. Syam B, Owens D. Horner's syndrome in severe tetanus. Postgrad Med J 1992; 68: 279-280.
44. Schon F, O'Dowd L, White J, Begg N. Tetanus: delay in diagnosis in England and Wales. J Neurol Neurosurg Psych 1994; 57: 1006-1007.
45. Apte NM, Karnard DR. Short report: the spatula test: a simple bedside test to diagnose tetanus. Am J Trop Med Hyg 1995; 53: 386-387.
46. Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J 1985; 29: 648-650.
47. Faust RA, Vickers OR, Cohn I. Tetanus: 2449 cases in 68 years at Charity Hospital. J Trauma 1976; 16: 705-712.
48. Schmitt A, Dreyer F, John C. At least three sequential steps are involved in the tetanus toxin-induced block of neuromuscular transmission. Naunyn-Schmiedebergs Arch Pharmacol 1981; 317: 326-330.
49. Sherrington SC. Observations with antitetanus serum in the monkey. Lancet 1917; ii: 964-966.
50. Sanders RKM, Joseph R, Martyn B, Peacock ML. Intrathecal antitetanus serum (horse) in the treatment of tetanus. Lancet 1977; i: 974-977.
51. Singh AK, Bangal A, Goel SP, Agarwal VK. Intrathecal antitetanus serum (horse) with steroid in the treatment of neonatal tetanus. Arch Dis Child 1980; 55: 527-531.
52. Gupta PS, Kapoor R, Goyal S, Batra VK, Jain BK. Intrathecal human tetanus immunoglobulin in early tetanus. Lancet 1980; ii: 439-440.
53. Abrutyn E, Berlin JA. Intrathecal therapy in tetanus. A meta analysis. JAMA 1991; 266: 2262-2267.
54. Elechi CA. Neuroleptic malignant syndrome complicating tetanus treated with chlorpromazine. Trop Doct 1992; 22: 92-93.
55. Guzman JA, Guerrero A, Lopez-Obispo M et al. Continuous perfusion with midazolam and atracurium in a patient with severe tetanus. Revist Espanol Anestesiol Reanim 1993; 40: 375.
56. Gyasi HK, Fahr J, Kurian E, Mathew M. Midazolam for prolonged intravenous sedation in patients with tetanus. Middle East J Anesthesiol 1993; 12: 135-141.
57. Stevens JJ, Griffin RM, Stow PJ. Prolonged use of isoflurane in a patient with tetanus. Br J Anaesth 1993; 70: 107-109.
58. Patten D, Martin KF, Halliwell RF. A study of the effect of propofol on neuronal GABA(A), 5HT-3, P2X and nACh receptors. Br J Pharmacol 1996; 117: 135.
59. Orko R, Rosenberg PH, Himberg JJ. Intravenous infusion of midazolam, propofol and vecuronium in a patient with severe tetanus. Acta Anaesthesiol Scand 1988; 32: 590-592.
60. Smitz S, Cohen AI, Sadzot B. Mephenesine in tetanus. J Amer Geriat Soc 1995; 43: 836-837.
61. Saissy JM, Demaziere J, Vitris M et al. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med 1992; 18: 241-244.
62. Brock H, Moosbauerk W, Gabriel C. Treatment of severe tetanus by continuous intrathecal infusion of baclofen. J Neurosurg Psych 1995; 59: 192-199.
63. Agular Bernai OR, Bender MA, Lacy ME. Efficacy of dantrolene sodium in management of tetanus in children. J Roy Soc Med 1986; 79: 277-282.
64. Checketts MR, White RJ. Avoidance of intermittent positive pressure ventilation in tetanus with dantrolene therapy. Anaesthesia 1993; 48: 969-971.
65. Prys-Roberts C, Corbett JL, Kerr JH, Crampton Smith A, Spalding JMK. Treatment of sympathetic overactivity in tetanus. Lancet 1969; i: 542-546.
66. Southhorn PA, Biaise GA. Treatment of tetanus induced autonomic nervous system dysfunction with continuous epidural blockade. Crit Care Med 1986; 14: 251-252.
67. Rocke DA, Wesley AG, Pather M, Calver AD, Harisparsad D. Morphine in tetanus, the management of sympathetic nervous system overactivity. S Afr Med J 1986; 70: 666-668.
68. Sutton DN, Tremlett TE, Woodcock TE, Nielsen MS. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med 1990; 16: 75-80.
69. James MFM, Huddle KRL, Owen AD, Veen BW van der. Use of magnesium sulphate in the anaesthetic management of pheochromocytoma in pregnancy. Can J Anaesth 1988; 35: 178-182.
70. James MFM, Manson EDM. The use of magnesium sulphate infusions of very severe tetanus. Intensive Care Med 1985; 11: 5-12.
71. Sykes MK. Intermittent positive pressure respiration in tetanus neonatorum. Anaesthesia 1960; 15: 401-410.
72. Long AP, Sartwell PE. Tetanus in US Army in World War II. Bull US Army Med Dept 1947; 7: 371-375.
73. Walker AM, Jick H, Perera DR, Knauss TA, Thompson RS. Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics 1988; 81: 345-349.
74. Anderson EL, Belshe RB, Bartram J. Differences in reactogenicity and antigenicity of a cellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. J Infect Dis 1988; 157: 731-737.
75. Maclennan R, Schofield FD, Pittman M et al. Immunization against neonatal tetanus in New Guinea: antitoxin response of pregnant women to adjuvant and plain toxoids. Bull WHO 1965; 32: 683-697.
76. Leshman Y, Herman J. Tetanus immunity in kibbutz women. Israel J Med Sci 1989; 25: 127-130.
77. Cumberland NS, Kidd AG, Karalliedde L. Immunity to tetanus in United Kingdom populations. J Infect 1993; 27: 255-260.
78. Greenwood BM, Bradley-Moore AM, Bryceson AD, Palit A. Immunosuppression in children with malaria. Lancet 1972; i: 169-172.
79. Brabin BJ, Nagel J, Hagenaars AM, Rintenberg E, van Tilborgh AM. The influence of malaria and gestation on the immune response to one or two doses of adsorbed tetanus toxoid in pregnancy. Bull WHO 1984; 62: 919-930.
80. Teeuwsen VJ, Logtenberg J, Siebelink KH, Lange JM, Goudsmit J, Uytdehaag FG, Osterhaus AD. Analysis of the antigen and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell dependent and T cell independent activation. J Immunol 1987; 139: 2929-2935.
81. Opravil M, Fierz W, Matter L, Blaser J, Luthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised HIV infected patients. Clin Exper Immunol 1991; 84: 185-189.
82. Lennard TWJ, Gunn A, Sellers J, Stoddart JC. Tetanus after elective cholecystectomy and exploration of common bile duct. Lancet 1984; i: 1466-1467.
83. Parker L, Mandal BK. Post-operative tetanus. Lancet 1984; ii: 407.